1] Viral entry. Within the Paramyxoviridae family, Nipah virus (NiV) and Hendra virus (HeV) cause the highest mortality rates (40-100%) in humans. This viral family includes important human and veterinary pathogens, such as measles, mumps, human parainfluenza, canine distemper, and Newcastle disease viruses. There are many questions regarding paramyxoviral infections that remain elusive. Our recent studies identified several novel domains in the viral glycoproteins G and F that are important for modulating the viral-cell membrane fusion process during viral entry, as well as cell-cell fusion upon viral infection of a host cell. We aim to understand the steps in the viral entry process these domains in G and F modulate. We use novel approaches that allow us to study the steps of viral entry, such as receptor binding, fusion triggering, hemifusion, fusion pore formation, and syncytia formation on cells and on virions. Novel approaches include Flow Virometry and Raman Spectroscopy.
2] Viral egress. Using multi-omics approaches, we recently identified cellular factors involved in viral entry, assembly, and budding out of infected cells. We are using this knowledge to study the mechanisms by which viral and cellular factors interact to modulate viral assembly and egress from infected host cells. Importantly, we connect this knowledge to the study of viral pathogenesis via established biosafety level 4 collaborations.
3] Immune responses and vaccine development. Viral-like particles are non-replication-competent units that resemble the respective actual viruses. Our data has shown that NiV and HeV viral-like particles are useful to generate highly-neutralizing conformational antibodies to NiV and HeV. We investigate whether NiV and HeV viral-like particles and pseudotyped viral particles can be useful vaccine platforms to protect against NiV, HeV, and other emerging paramyxoviruses and enveloped viruses beyond this family. We also investigate broadly applicable new technologies to advance vaccine development.
4] Antivirals. We take both empirical and targeted approaches. Our main interests include the search for antiviral agents with broad antiviral applications, with a special interest in those to be used against enveloped viruses. Our membrane fusion studies foster the discovery of broad-spectrum antivirals that target enveloped viruses. We characterize the mechanisms of action of several families of broad-spectrum antiviral compounds.
BS Biochemical Engineering Institito Tecnologico de Tepic
MS Biology California State University, Los Angeles
PhD Biochemistry and Mol. Biol. University of Southern California
Dr. Aguilar-Carreno (publication name Hector C. Aguilar) is an Associate Professor in the Department of Microbiology and Immunology at Cornell University since July, 2017. He started his own research laboratory as an Assistant Professor at the Paul G. Allen School for Global Animal Health at Washington State University (WSU). He received a B.S. degree in Biochemical Engineering from Instituto Tecnologico de Tepic, Mexico. He then immigrated to the USA and obtained a M.S. degree in Biology from the California State University, Los Angeles, and a PhD degree in Biochemistry and Molecular Biology from the University of Southern California. He received post-doctoral training in Virology at the University of California, Los Angeles, under the mentoring of Dr. Benhur Lee. At UCLA he helped identify the cell receptors for Nipah virus (NiV) and Hendra virus (HeV) and began to establish important tools to study NiV and HeV entry into mammalian host cells. His laboratory is known for adopting technologies previously seen as foreign to the field of Virology, including Raman Spectroscopy and Flow Virometry, to the study of viruses. Dr. Aguilar has served as the WSU Chair of the Immunology and Infectious Diseases Executive Committee, a member of the WSU College of Veterinary Medicine research committee, a member of the WSU Internal Governance Board for the NIH T32 post-doctoral program, a trainer of five PhD students in the WSU NIH Biotechnology doctoral training program, a member of the American Society for Virology Education Committee, a ad-hoc member of over a dozen NIH study sections, a Chair and member of the American Society of Microbiology Committee for Minority Education, a Chair of the Cornell College of Veterinary Medicine Diversity Committee, a member of the Cornell CVM Research Committee, and a member of the Cornell presidential postdoctoral fellowship committee, among other roles.
Dr. Aguilar has an citation H index > 22, and > 50 peer-reviewed publications, found here: